In the present study, we found that the deletion of VSIG4 effectively inhibited the development and metastasis of cancers, and the anti-VSIG4 antibody had potent therapeutic effects in a variety of mouse transplanted tumor models. This evidence concerns the gene VSIG4 and neoplasm.